Patent application number | Description | Published |
20110187660 | MOBILE TYPE IMAGE DISPLAY DEVICE, METHOD FOR CONTROLLING THE SAME AND INFORMATION MEMORY MEDIUM - Provide is a portable image display device which allows a user to perform many different operation inputs with ease. The portable image display device includes: a display screen having a substantially rectangular shape; and a plurality of touch sensors provided along at least two sides defining a circumference of the display screen, for each detecting a position touched by a finger of a user. The portable image display device changes an image displayed on the display screen in accordance with a combination of the positions of a plurality of the fingers which are respectively detected by the plurality of touch sensors. | 08-04-2011 |
20120130667 | CALIBRATION APPARATUS, CALIBRATION METHOD, AND MANUFACTURING METHOD FOR AN ELECTRONIC DEVICE - Provided is a calibration apparatus, including: a holder for fixing an electronic device; a first motor for rotating the holder with a first rotation axis as a center; a second motor for rotating the holder with a second rotation axis perpendicular to the first rotation axis as a center; and a stopper for restricting a rotational position of the holder about the second rotation axis to a range between a reference position and a perpendicular position reached by rotating the holder by 90 degrees from the reference position, in which the first motor rotates the holder to which the electronic device is fixed at a predetermined speed in each of states in which the rotational position of the holder about the second rotation axis falls in the reference position and in which the rotational position of the holder about the second rotation axis falls in the perpendicular position. | 05-24-2012 |
20130328928 | OBSTACLE AVOIDANCE APPARATUS AND OBSTACLE AVOIDANCE METHOD - An obstacle detecting unit detects an obstacle for a user wearing a head mounted display from an image of the outside world. A distance calculating unit calculates the distance from a detected obstacle to the user wearing the head mounted display. An obstacle replacing unit replaces the detected obstacle with a virtual object. A virtual object synthesizing unit generates a virtual object at a position within a virtual space displayed on the head mounted display, in which the position is determined according to the distance to the obstacle. | 12-12-2013 |
20140015813 | INPUT APPARATUS USING CONNECTABLE BLOCKS, INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSOR, AND INFORMATION PROCESSING METHOD - A block tool, which can be assembled by a user, is configured with multiple types of blocks and is shot by a camera for capturing a still image or a moving image. The position coordinates of a marker of the square-pillar block in a three-dimensional space are obtained by image recognition. Also, a connecting position and the type of each block, a gradient vector of the square-pillar block, an angle between two blocks constituting the square-pillar block, and the respective blocks' lengths are obtained so as to derive the shape, posture, and position of the block tool, and corresponding information processing is then performed. | 01-16-2014 |
20140094309 | CONTROLLER DEVICE - Provided is a controller device capable of performing various operation inputs to an information processor via an attachment despite the attachment not being provided with an electrical circuit. The controller device includes a core unit having a touch sensor disposed on a surface thereof, and an attachment that is attached to the core unit so as to cover the touch sensor. The attachment is provided with an operation member that is configured so as to be able to contact the touch sensor in a state where the attachment is attached to the core unit, the contact mode with respect to the touch sensor changing in accordance with user operation. | 04-03-2014 |
20140323219 | MANIPULATOR AND MANIPULATION APPARATUS - A manipulator includes a manipulation body having a plurality of bar-shaped portions which intersect orthogonally with each other at one intersection point, and a plurality of detection bodies which detect a displacement of the manipulation body. The plural bar-shaped portions include a bar-shaped portion and another bar-shaped portion which intersect orthogonally with each other. The plural detection bodies include a first detection body which detects a displacement of one end side of the bar-shaped portion with respect to the intersection point, a second detection body which detects a displacement of the other end side of the bar-shaped portion with respect to the intersection point, and a third detection body which detects a displacement of one end side of the bar-shaped portion with respect to the intersection point. | 10-30-2014 |
20150116453 | IMAGE CAPTURING DEVICE, AND IMAGE CAPTURING METHOD - A multiview imaging part includes a plurality of imaging units. An exposure setting section individually sets an exposure value in each of the plurality of imaging units. The exposure setting section sets, in each of the imaging units, an individual reference exposure value and relative exposure values. The relative exposure values are obtained by changing the reference exposure value in a given number of steps in such a manner that the relative exposure values are centered around the reference exposure value. A panoramic image storage section stores captured images having different exposure values captured by the imaging units whose exposure values have been set by the exposure setting section. An HDR synthesis section synthesizes the captured images having different exposure values so as to generate a captured image having an adjusted dynamic range. | 04-30-2015 |
20150145952 | IMAGE CAPTURING DEVICE AND IMAGE CAPTURING METHOD - A bus interface/camera control interface connects a processor and a plurality of imaging units. A control data pass-through logic exchanges data between the bus interface/camera control interface and the plurality of imaging units. A pass-through mask register includes: a write register used to specify, of the plurality of imaging units, one or more imaging units to be selected so as to selectively supply write data to the one or more imaging units; and a read register used to specify, of the plurality of imaging units, a single imaging unit to be selected so as to selectively receive read data from the single imaging unit. The control data pass-through logic use the pass-through mask register to switch between input and output operations. | 05-28-2015 |
20150162048 | IMAGE GENERATION DEVICE AND IMAGE GENERATION METHOD - Frame memories store captured images supplied from a plurality of imaging units, respectively. A motion detection portion detects the motion of a captured image of at least one of the imaging units. A mode determination portion sets, in accordance with at least either the amount of the motion detected by the motion detection portion or a power consumption limit of the image generation device, one of two modes, one for operating the plurality of imaging units simultaneously and the other for operating the plurality of imaging units intermittently. A control signal generation portion supplies, to the plurality of frame memories, a control signal adapted to control reading of the captured images from the plurality of frame memories in accordance with the mode set by the mode determination portion. | 06-11-2015 |
20150163473 | IMAGE GENERATING DEVICE AND IMAGE GENERATING METHOD - An image generating device configured to provide a cloud service to a head-mounted display via a network is provided. A photographed image receiving section | 06-11-2015 |
20150235530 | Haptic Device - There is provided a haptic device including a small-size haptic unit. The haptic device includes a weight, a magnet fixed to the weight, a coil that generates a magnetic field to reciprocate the magnet along a predetermined direction, and a current control unit that presents a haptic sensation to a user by controlling a current flowing in the coil to vibrate the weight. | 08-20-2015 |
Patent application number | Description | Published |
20100028373 | PEPTIDE VACCINES FOR CANCERS EXPRESSING MPHOSPH1 OR DEPDC1 POLYPEPTIDES - The present invention provides peptides having an amino acid sequence as set forth in SEQ ID NO: 7, 8, 9, 10, 11, 12, 192, 195, 197, 209, 225, 226, 228, 230, 240, 241, 243, 244, 249, 253, 254 or 255, as well as peptides having the above-mentioned amino acid sequences in which 1, 2, or several amino acids are substituted, deleted, or added, wherein the peptides possess cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing a disease associated with the over-expression of MPHOSPH1 and/or DEPDC1, e.g. cancers, containing these peptides as an active ingredient. The peptides of the present invention can also be used as vaccines. | 02-04-2010 |
20100092501 | FOXP3 PEPTIDE VACCINE - The present invention provides Foxp3 peptides comprising the amino acid sequence of SEQ ID NOs: 3-5, 7-9, 12, 15-19, 22, 24, 27-30, 37, 67 or 74, and Foxp3 peptides comprising the above-mentioned amino acid sequences in which 1, 2, or several amino acids are substituted or added, and having cytotoxic T cell inducibility, and also provides drugs for regulating regulatory T cells comprising these Foxp3 peptides. The Foxp3 peptides of this invention find use as vaccines. | 04-15-2010 |
20110052614 | STAT3 EPITOPE PEPTIDES - The present invention provides peptides comprising the amino acid sequence of SEQ ID NO: 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 19, 20, 21, 22, 26, 27, 29, 30, 59, 61, 63, 64, 65, 66, 67, 68, 69, 70, 72, 73, 74, 75, 77, 83, 94, 96, 97, 98 or 103, and peptides comprising one of the above-mentioned amino acid sequences with substitution or addition of one, two, or several amino acids, and having cytotoxic T cell inducibility, and also provides drugs comprising these peptides. The peptides of this invention can be used as vaccines. | 03-03-2011 |
20120093843 | TEM8 PEPTIDES AND VACCINES COMPRISING THE SAME - According to the present invention, peptides comprising the amino acid sequence of SEQ ID NO: 3, 4, 9, 23, 25, 30, 60, 63 or 68 were demonstrated to have cytotoxic T lymphocyte (CTL) inducibility. Therefore, the present invention provides a peptide having the amino acid sequence selected from the group of SEQ ID NOs: 3, 4, 9, 23, 25, 30, 60, 63 and 68. The peptide can include one, two, or several amino acid substitutions or addition so long as its CTL inducibility is retained. Furthermore, the present invention provides pharmaceutical agents for treating and/or prophylaxis of tumors, and/or prevention of postoperative recurrence thereof, which comprises any of these peptides. The pharmaceutical agents of this invention include vaccines. | 04-19-2012 |
20130224234 | TTLL4 PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. In particular, epitope peptides derived from the TTLL4 gene that elicit CTLs are provided. Antigen-presenting cells and isolated CTLs that target such peptides, as well as methods for inducing the antigen-presenting cell, or CTL are also provided. The present invention further provides pharmaceutical compositions containing peptides derived from TTLL4 or polynucleotides encoding the polypeptides as active ingredients. Furthermore, the present invention provides methods for the treatment and/or prophylaxis of (i.e., preventing) cancers (tumors), and/or the prevention of a postoperative recurrence thereof, as well as methods for inducing CTLs, methods for inducing anti-tumor immunity, using the peptides derived from TTLL4, polynucleotides encoding the peptides, or antigen-presenting cells presenting the peptides, or the pharmaceutical compositions of the present invention. | 08-29-2013 |
20130287805 | C18ORF54 PEPTIDES AND VACCINES INCLUDING THE SAME - Peptide vaccines against cancer are described herein. In particular, isolated epitope peptides or immunogenic fragments derived from SEQ ID NO: 35, that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) are provided. The amino acid sequences of the peptide of interest may be optionally modified with the substitution, deletion, insertion, or addition of one, two, or several amino acids sequences. Pharmaceutical compositions and methods of treating cancer that include such peptides are also provided. | 10-31-2013 |
20130309259 | WDHD1 PEPTIDES AND VACCINES INCLUDING THE SAME - Peptide vaccines against cancer are described herein. In particular, isolated epitope peptides or immunogenic fragments derived from SEQ ID NO: 32, that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) are provided. The amino acid sequence of the peptide of interest may be optionally modified with the substitution, deletion, insertion, or addition of one, two, or several amino acids sequences. Pharmaceutical compositions and methods of treating cancer that include such peptides are also provided. | 11-21-2013 |
20140023671 | TOMM34 PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 42, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for treating cancer. | 01-23-2014 |
20140154281 | MPHOSPH1 PEPTIDES AND VACCINES INCLUDING THE SAME - As discussed in greater detail herein, isolated epitope peptides derived from MPHOSPH1 bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines. The inventive peptides encompass both the above-mentioned MPHOSPH1-derived amino acid sequences and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted or added, provided such modified versions retain the requisite CTL inducibility of the original sequences. Further provided are polynucleotides encoding any of the aforementioned peptides as well as pharmaceutical agents or compositions that include any of the aforementioned peptides or polynucleotides. The peptides, polynucleotides, and pharmaceutical agents or compositions of this invention find particular utility in either or both of the treatment and prevention of cancers and tumors, including, for example, bladder cancer, breast cancer, cervical cancer, cholangiocellular carcinoma, CML, colorectal cancer, gastric cancer, NSCLC, lymphoma, osteosarcoma, prostate cancer, renal cancer and soft tissue tumor. | 06-05-2014 |
20140178409 | SEMA5B PEPTIDES AND VACCINES INCLUDING THE SAME - As discussed in detail herein, isolated epitope peptides derived from SEMA5B bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines. The inventive peptides encompass both the above mentioned amino acid sequences and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted or added, provided such modified versions retain the requisite HLA binding and/or CTL inducibility of the original sequences. Further provided are polynucleotides encoding any of the aforementioned peptides as well pharmaceutical agents or compositions that include any of the aforementioned peptides or polynucleotides. The peptides, polynucleotides, pharmaceutical agents or compositions of this invention find particular utility in the treatment and/or prevention of cancers and tumors, including, for example, esophageal cancer, NSCLC, RCC and SCLC. | 06-26-2014 |
20140255437 | TOPK PEPTIDES AND VACCINES INCLUDING THE SAME - The present invention provides isolated epitope peptides derived from TOPK and immunogenic fragments thereof have an ability to induce cytotoxic T lymphocytes (CTLs) and thus are suitable for use in cancer immunotherapy, more particularly as cancer vaccines. The peptides of the present invention encompass both of peptides including a TOPK-derived amino acid sequence and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted and/or added, provided such modified versions have CTL inducibility. Further provided are polynucleotides encoding any of the aforementioned peptides as well as pharmaceutical compositions that include any of the aforementioned peptides or polynucleotides. The peptides, polynucleotides, and pharmaceutical compositions of this invention find particular utility in either or both of the treatment and prevention of a number of cancers. | 09-11-2014 |
20150174223 | UBE2T PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. In particular, epitope peptides derived from the UBE2T that elicit CTLs are provided. Isolated antigen-presenting cells with CTL inducibility and CTLs that target such peptides, as well as methods for inducing the antigen-presenting cell, or CTL are also provided. The present invention further provides pharmaceutical compositions containing such epitope peptides derived from UBE2T or polynucleotides encoding the polypeptides as active ingredients. Furthermore, the present invention provides methods for the treatment and/or prophylaxis of (i.e., preventing) cancers (tumors), and/or the prevention of a postoperative recurrence thereof, as well as methods for inducing CTLs, methods for inducing anti-tumor immunity, using the epitope peptides derived from UBE2T, polynucleotides encoding the peptides, or antigen-presenting cells presenting the peptides, or the pharmaceutical compositions of the present invention. | 06-25-2015 |
20150190489 | KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME - Isolated KIF20A-derived epitope peptides having Th1 cell inducibility are disclosed herein. Such peptides can be recognized by MHC class II molecules and induce Th1 cells. In preferred embodiments, such a peptide of the present invention can promiscuously bind to MHC class II molecules and induce KIF20A-specific cytotoxic T lymphocytes (CTLs) in addition to Th1 cells. Such peptides are thus suitable for use in enhancing immune response in a subject, and accordingly find use in cancer immunotherapy, in particular, as cancer vaccines. Also disclosed herein are polynucleotides that encode any of the aforementioned peptides, APCs and Th1 cells induced by such peptides and methods of induction associated therewith. Pharmaceutical compositions that comprise any of the aforementioned components as active ingredients find use in the treatment and/or prevention of cancers or tumors. | 07-09-2015 |
20150190490 | CDCA1 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME - Isolated CDCA1-derived epitope peptides having Th1 cell inducibility are disclosed herein. Such peptides can be recognized by MHC class II molecules and induce Th1 cells. In preferred embodiments, such a peptide of the present invention can promiscuously bind to MHC class II molecules and induce CDCA1-specific cytotoxic T lymphocytes (CTLs) in addition to Th1 cells. Such peptides are thus suitable for use in enhancing immune response in a subject, and accordingly find use in cancer immunotherapy, in particular, as cancer vaccines. Also disclosed herein are polynucleotides that encode any of the aforementioned peptides, APCs and Th1 cells induced by such peptides and methods of induction associated therewith. Pharmaceutical compositions that comprise any of the aforementioned components as active ingredients find use in the treatment and/or prevention of cancers or tumors. | 07-09-2015 |
20150191516 | LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME - Isolated LY6K-derived epitope peptides having Th1 cell inducibility are disclosed herein. Such peptides can be recognized by MHC class II molecules and induce Th1 cells. In preferred embodiments, such a peptide of the present invention can be promiscuously bind to MHC class II molecules and induce LY6K-specific cytotoxic T lymphocytes (CTLs) in addition to Th1 cells. Such peptides are thus suitable for use in enhancing immune response in a subject, and accordingly find use in cancer immunotherapy, in particular, as cancer vaccines. Also disclosed herein are polynucleotides that encode any of the aforementioned peptides, APCs and Th1 cells induced by such peptides and methods of induction associated therewith. Pharmaceutical compositions that comprise any of the aforementioned components as active ingredients find use in the treatment and/or prevention of cancers or tumors. | 07-09-2015 |
20150322112 | SEMA5B PEPTIDES AND VACCINES CONTAINING THE SAME - Peptide vaccines against cancer are described herein. Isolated epitope peptides derived from the SEMA5B gene that elicit CTLs and thus are suitable for use in the context of cancer immunotherapy are provided. The peptides encompass both SEMA5B-derived peptides and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted or added, provided such modified versions retain the requisite CTL inducibility of the original sequences. Further provided are polynucleotides encoding such peptides as well as pharmaceutical compositions that include any such peptides or polynucleotides as active agents. Antigen-presenting cells and isolated CTLs that target such peptides, as well as methods for inducing the antigen-presenting cell, or CTL are also provided. Furthermore, the present invention provides methods for use in cancer immunotherapy. | 11-12-2015 |
Patent application number | Description | Published |
20080256639 | Verification Method, Information Processing Device, Recording Medium, Verification System, Certification Program, and Verification Program - A virtual machine can be implemented by anyone because the interface and other information necessary for implementation are publicly available. Hence, if virtual machine is implemented maliciously, a program operating thereon can be made to operate maliciously instead of operating legitimately. | 10-16-2008 |
20090323943 | DATA TRANSMISSION SYSTEM - A cipher key is generated by first information shared in secrete between a data transmitting unit | 12-31-2009 |
20100054462 | INFORMATION RECORDING/REPRODUCING APPARATUS AND METHOD - A block key to encrypt block data is generated using an ATS (arrival time stamp) appended to each of TS (transport stream) packets included in a transport stream correspondingly to the arrival time of the TS packet. The ATS is a random data depending upon an arrival time, and so a block-unique key can be generated, which enhances the protection against data cryptanalysis. A block key is generated from a combination of an ATS with a key unique to a device, recording medium or the like such as a master key, disc-unique key, title-unique key or the like. Since an ATS is used to generate a block key, any area for storage of an encryption key for each block may not be provided in a recording medium. | 03-04-2010 |
20100251357 | DATA TRANSMITTING SYSTEM AND METHOD, DRIVE UNIT, ACCESS METHOD, DATA RECORDING MEDIUM, RECORDING MEDIUM PRODUCING APPARATUS AND METHOD - A security module is provided in a data recording medium, data to be written to the data recording medium is encrypted with an content key different from one data to another, and the content key is safely stored in the security module. Also, the security module makes a mutual authentication using the public-key encryption technology with a drive unit to check that the counterpart is an authorized (licensed) unit, and then gives the content key to the counterpart, thereby preventing data from being leaked to any illegal (unlicensed) unit. Thus, it is possible to prevent copyrighted data such as movie, music, etc. from being copied illegally (against the wish of the copyrighter of the data). | 09-30-2010 |
20100290619 | ENCIPHERING APPARATUS AND METHOD, DECIPHERING APPARATUS AND METHOD AS WELL AS INFORMATION PROCESSING APPARATUS AND METHOD - The invention provides an enciphering apparatus and method, a deciphering apparatus and method and an information processing apparatus and method by which illegal copying can be prevented with certainty. Data enciphered by a 1394 interface of a DVD player is transmitted to a personal computer and a magneto-optical disk apparatus through a 1394 bus. In the magneto-optical disk apparatus with which a change to a function is open to a user, the received data is deciphered by a 1394 interface. In contrast, in the personal computer with which a change to a function is open to a user, the enciphered data is deciphered using a time variable key by a 1394 interface, and a result of the decipherment is further deciphered using a session key by an application section. | 11-18-2010 |
20110274272 | DATA TRANSMISSION SYSTEM - A cipher key is generated by first information shared in secrete between a data transmitting unit | 11-10-2011 |
20120257744 | ENCIPHERING APPARATUS AND METHOD, DECIPHERING APPARATUS AND METHOD AS WELL AS INFORMATION PROCESSING APPARATUS AND METHOD - The invention provides an enciphering apparatus and method, a deciphering apparatus and method and an information processing apparatus and method by which illegal copying can be prevented with certainty. Data enciphered by a 1394 interface of a DVD player is transmitted to a personal computer and a magneto-optical disk apparatus through a 1394 bus. In the magneto-optical disk apparatus with which a change to a function is open to a user, the received data is deciphered by a 1394 interface. In contrast, in the personal computer with which a change to a function is open to a user, the enciphered data is deciphered using a time variable key by a 1394 interface, and a result of the decipherment is further deciphered using a session key by an application section. | 10-11-2012 |
20130236008 | DATA TRANSMISSION SYSTEM - A cipher key is generated by first information shared in secrete between a data transmitting unit | 09-12-2013 |
20130239174 | DATA TRANSMITTING SYSTEM AND METHOD, DRIVE UNIT, ACCESS METHOD, DATA RECORDING MEDIUM, RECORDING MEDIUM PRODUCING APPARATUS AND METHOD - A security module is provided in a data recording medium, data to be written to the data recording medium is encrypted with an content key different from one data to another, and the content key is safely stored in the security module. Also, the security module makes a mutual authentication using the public-key encryption technology with a drive unit to check that the counterpart is an authorized (licensed) unit, and then gives the content key to the counterpart, thereby preventing data from being leaked to any illegal (unlicensed) unit. Thus, it is possible to prevent copyrighted data such as movie, music, etc. from being copied illegally (against the wish of the copyrighter of the data). | 09-12-2013 |
20140115342 | INFORMATION PROCESSING APPARATUS, INFORMATION STORAGE MEDIUM, CONTENT MANAGEMENT SYSTEM, DATA PROCESSING METHOD, AND COMPUTER PROGRAM - A configuration for achieving efficient content verification processing based on hash values is provided. Hash values of hash units set as segmented data of a content stored on an information storage medium are recorded in a content hash table and are stored on the information storage medium together with the content. An information processing apparatus for executing content playback executes hash-value comparison processing based on one or more randomly selected hash values. Regardless of the data amount of content, the configuration can perform hash-value determination and comparison processing based on hash units having a small amount of data, so that user equipment for executing content playback can perform efficient content verification. | 04-24-2014 |
20150317460 | COPY PROTECTION USING DETAILED COPY CONTROL INFORMATION - Based on the detailed reproduction control information defining the reproduction control state of data to be transmitted, the CPU | 11-05-2015 |